日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia

通过非活性位点抑制抗体靶向抑制活化蛋白C治疗血友病

Xiao-Yan Zhao, Andreas Wilmen, Dongli Wang, Xinquan Wang, Maxine Bauzon, Ji-Yun Kim, Lars Linden, Liang Li, Ursula Egner, Tobias Marquardt, Dieter Moosmayer, Jan Tebbe, Julian Marius Glück, Philipp Ellinger, Kirk McLean, Shujun Yuan, Subramanian Yegneswaran, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu

Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer

BAY 1129980(一种新型基于奥瑞他汀的抗 C4.4A(LYPD3)抗体-药物偶联物)用于治疗非小细胞肺癌的临床前抗肿瘤疗效

Jörg Willuda, Lars Linden, Hans-Georg Lerchen, Charlotte Kopitz, Beatrix Stelte-Ludwig, Carol Pena, Claudia Lange, Sven Golfier, Christoph Kneip, Patricia E Carrigan, Kirk Mclean, Joachim Schuhmacher, Oliver von Ahsen, Jörg Müller, Frank Dittmer, Rudolf Beier, Sherif El Sheikh, Jan Tebbe, Gabriele L

Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β

使用新型脑啡肽酶持续消耗外周β-淀粉样蛋白不会影响中枢β-淀粉样蛋白的水平

Simon J Henderson, Christin Andersson, Rajesh Narwal, Juliette Janson, Tom J Goldschmidt, Paulina Appelkvist, Anna Bogstedt, Ann-Charlott Steffen, Ulrich Haupts, Jan Tebbe, Per Ola Freskgård, Lutz Jermutus, Matthew Burrell, Susan B Fowler, Carl I Webster

Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease

设计脑啡肽酶活性和特异性以创造一种治疗阿尔茨海默病的新方法

Carl I Webster, Matthew Burrell, Lise-Lotte Olsson, Susan B Fowler, Sarah Digby, Alan Sandercock, Arjan Snijder, Jan Tebbe, Ulrich Haupts, Joanna Grudzinska, Lutz Jermutus, Christin Andersson